Keane K. Y. Lai
- Hepatology top 5%
- Liver physiology and pathology 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 7
- Hepatitis B Virus Studies 3
-
- Wnt/β-catenin signaling in development and cancer 8
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
-
- Pancreatic and Hepatic Oncology Research 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Hidekazu TsukamotoLaura BerettaSamuel W. FrenchDeepak KolippakkamAurelia LugeaMarcus P. CooperAlla VerlinskyCheng Ji
- Partner nations
- United StatesJapanHong Kong
In The Last Decade
Keane K. Y. Lai
25 papers receiving 733 citations
Peers
Comparison fields: 5 of 82
- Hepatology 130
- Cancer Research 117
- Epidemiology 264
- Pathology and Forensic Medicine 99
- Molecular Biology 344
Countries citing papers authored by Keane K. Y. Lai
This map shows the geographic impact of Keane K. Y. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keane K. Y. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keane K. Y. Lai more than expected).
Fields of papers citing papers by Keane K. Y. Lai
This network shows the impact of papers produced by Keane K. Y. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keane K. Y. Lai. The network helps show where Keane K. Y. Lai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keane K. Y. Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2022 | 13 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 6 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 23 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 13 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 17 | |
| 12 | 2018 | 43 | |
| 13 | 2017 | 137 | |
| 14 | 2017 | 16 | |
| 15 | 2016 | 23 | |
| 16 | 2013 | 32 | |
| 17 | 2011 | 77 | |
| 18 | 2011 | 28 | |
| 19 | 2011 | 123 | |
| 20 | 2008 | 58 |
About Keane K. Y. Lai
Keane K. Y. Lai is a scholar working on Hepatology, Oncology and Toxicology, having authored 25 papers that have together received 741 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Cancer-related gene regulation (4 papers), Liver physiology and pathology (3 papers), Epigenetics and DNA Methylation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Hepatitis B Virus Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Hepatology (130 citations), Cancer Research (117 citations) and Epidemiology (264 citations). Keane K. Y. Lai has collaborated with scholars based in United States, Japan and Hong Kong. Frequent co-authors include Hidekazu Tsukamoto, Laura Beretta, Samuel W. French, Deepak Kolippakkam, Aurelia Lugea, Marcus P. Cooper, Alla Verlinsky, Cheng Ji, Jun Xu and Jane F. Emerson. Their work appears in journals such as Cancers, PLoS ONE, Current Molecular Pharmacology, Scientific Reports and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.